CI Global Health Sciences Corporate Class

Series P USD
 

Fund overview

This fund invests primarily in equity and equity-related securities of companies around the world that specialize in the health care or medical industry.

Fund details

description of elementelement value
Inception date May 2017
CAD Total net assets ($CAD)
As at 2025-07-30
$143.9 million
NAVPS
As at 2025-08-29
$8.5640
MER (%)
As at 2025-03-31
0.24
Management fee (%) 0.90
Asset class Sector Equity
Currency USD
Minimum investment $500 initial/$25 additional
Distribution frequency Quarterly
Last distribution $0.1669

Risk rating1

  • Low
  • Low to medium
  • Medium
  • Medium to high
  • High

FUND CODES

P 90324
A ISC 301
DSC SO* 401
LL SO 1401
F 324
*No new purchases directly into switch only funds.

Performance2 As at 2025-08-31

Growth of $10,000 (Since inception date)

growth of 10k graph

Calendar year performance

annual performance graph

average annual compound returns

YTD 1 Mo 3 Mo 6 Mo 1 Y 3 Y 5 Y 10 Y Inception*
-2.65% 4.81% 4.33% -8.87% -19.72% 2.24% 1.64% - 3.81%
*Since inception date

Distribution history3

Payable date Total
2022-03-25 0.1669
2021-03-26 0.0563
2020-12-18 0.0892
2020-09-25 0.0844
2020-06-26 0.0615
Payable date Total
2020-03-20 0.1428
2019-12-13 0.0890
2019-09-27 0.0991
2019-06-21 0.0930
2019-03-22 0.1458

Management team

First we'll display the Team Company and then the Team members
Greg Quickmire
Peter Hofstra

CI Global Health Sciences Corporate Class

Series P USD
 
Portfolio allocations4 As at 2025-07-31
Asset allocation (%)
  • US Equity 85.32
  • International Equity 14.50
  • Cash and Equivalents 0.16
  • Other 0.02
Sector allocation (%)
  • Healthcare 99.82
  • Cash and Cash Equivalent 0.16
  • Other 0.02
Geographic allocation(%)
  • United States 83.16
  • United Kingdom 8.81
  • Switzerland 3.37
  • Germany 2.36
  • Canada 2.28
  • Other 0.02
Top holdings5
Sector (%)
1. Eli Lilly and Co Drugs 11.16%
2. AstraZeneca PLC Drugs 8.81%
3. Merck & Co Inc Drugs 8.41%
4. AbbVie Inc Drugs 8.33%
5. Thermo Fisher Scientific Inc Healthcare Equipment 8.15%
6. Danaher Corp Healthcare Equipment 6.25%
7. Stryker Corp Healthcare Equipment 4.94%
8. Gilead Sciences Inc Drugs 4.84%
9. Intuitive Surgical Inc Healthcare Equipment 4.76%
10. Boston Scientific Corp Healthcare Equipment 4.47%
11. IQVIA Holdings Inc Drugs 4.21%
12. Johnson & Johnson Drugs 4.11%
13. UnitedHealth Group Inc Healthcare Services 3.62%
14. Lonza Group AG Drugs 3.33%
15. Siemens Healthineers AG Healthcare Equipment 2.36%
Over 35,000 financial advisors have chosen CI Global Asset Management as a partner. We believe that Canadians have the best opportunity for investments success by using the services of a professional financial advisor. Learn more at ci.com.